Same Meds, New Patents: What Do Activists Need to Know About Long-Acting Formulations?
ResearchLong-Acting Formulations (LAFs) have the potential to make treatment for hepatitis C (HCV) and tuberculosis (TB) easier to adhere to,...
-
MMA’s partners in Kazakhstan call for systemic changes to the country’s intellectual property and access to medicines framework in their annual report
News ResearchAnswer Foundation and Antihepatitis C Foundation, MMA’s partners in Kazakhstan, with technical support from ITPC-Ru, recently launched a comprehensive Annual...
-
COVID-19 Community Resource: resource for access to COVID-19 medical technology
ResearchCOVID-19 has revealed – and drastically worsened – economic and social inequality on a global scale. Governmental decisions to prioritize...
Read more about COVID-19 Community Resource: resource for access to COVID-19 medical technology
-
-
The next COVID-19 crisis: A vaccine apartheid endangering us all
News ResearchThe West bought billions of vaccines fast and cheap, leaving poorer nations waiting longer and paying more. Published by The...
Read more about The next COVID-19 crisis: A vaccine apartheid endangering us all
-
New data demonstrates the impact of patents in Ukraine
News Research2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
Read more about New data demonstrates the impact of patents in Ukraine
-
Report: 10 years of community-monitoring of ARV procurement in Russia
News ResearchITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
Read more about Report: 10 years of community-monitoring of ARV procurement in Russia
-
COVID-19 pandemic: ‘An opportunity of a lifetime’?
News Research The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
Read more about COVID-19 pandemic: ‘An opportunity of a lifetime’?
-
Global headlines: Potential COVID-19 drugs are over-priced
News ResearchFrom the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
Read more about Global headlines: Potential COVID-19 drugs are over-priced
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Call to action News ResearchDrugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
